Photo by nci from unsplash
There are now 6 randomized controlled trials (RCTs) comparing dual (DAT) versus triple antithrombotic therapy (TAT) in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) or undergoing percutaneous… Click to show full abstract
There are now 6 randomized controlled trials (RCTs) comparing dual (DAT) versus triple antithrombotic therapy (TAT) in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) ([1][1]). The first 2 trials, WOEST (What is the
Keywords:
atrial fibrillation;
acs;
pci;
antithrombotic therapy
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!